Sitemap > Breaking Research > Diagnostics & Devices
Displaying 401 - 450 of 1058 results
- Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
- The ChemoFx(R) Assay: An Ex Vivo Chemosensitivity and Resistance Assay for Predicting Patient Response to Cancer Chemotherapy.
- Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes.
- Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: A semiquantitative study of immunoreactivities using tissue array.
- Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation.
- Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
- Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
- The Human Combinatorial Antibody Library HuCAL GOLD Combines Diversification of All Six CDRs According to the Natural Immune System with a Novel Display Method for Efficient Selection of High-Affinity Antibodies.
- Imaging of amyloid beta in Alzheimer's disease with (18)F-BAY94-9172, a novel PET tracer: proof of mechanism.
- Clinical efficacy and patient satisfaction with U-500 insulin pump therapy in patients with type 2 diabetes.
- Does Renin-Angiotensin Aldosterone System Blockade Exacerbate Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease? A Prospective 50-month Mayo Clinic Study.
- (111)In-Labeled Lactam Bridge-Cyclized alpha-Melanocyte Stimulating Hormone Peptide Analogues for Melanoma Imaging.
- Assessment of bevacizumab conjugated to cy5.5 for detection of head and neck cancer xenografts.
- Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting.
- A Multicenter Clinical Trial on the Diagnostic Value of Dual-Tracer PET/CT in Pulmonary Lesions Using 3'-Deoxy-3'-18F-Fluorothymidine and 18F-FDG.
- Development of an immunochromatographic strip for rapid detection of the H9 subtype of avian influenza viruses (H9AIVs).
- Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects.
- Selection of a novel drug-response predictor in esophageal cancer: A novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.
- Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: Diagnostic and prognostic implications.
- Novel Blood-Based, Five-Gene Biomarker Set for the Detection of Colorectal Cancer.
- Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies.
- Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.
- Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines.
- Expression of alpha(1)-Adrenoceptor Subtype mRNA as a Predictor of the Efficacy of Subtype Selective alpha(1)-Adrenoceptor Antagonists in the Management of Benign Prostatic Hyperplasia.
- Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastases in Patients With Breast Cancer.
- Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
- Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy.
- Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.
- Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection.
- Development and validation of a predictive model for chemotherapy-associated thrombosis.
- Development of Homogeneous 384-Well High-Throughput Screening Assays for A{beta}1-40 and A{beta}1-42 Using AlphaScreenTM Technology.
- Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator).
- Use of CoZmonitor((R)) in youth with type 1 diabetes.
- Synthesis and evaluation of stilbenylbenzoxazole and stilbenylbenzothiazole derivatives for detecting beta-amyloid fibrils.
- Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
- Breast cancer mortality with varying invitational policies in organised mammography.
- Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome.
- Efficacy of automatic mode switching in DDDR mode pacemakers: The most 2 study.
- Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis.
- Comparison of p16(INK4A) and Hybrid Capture(R) 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePathtrade mark preparations.
- Effectiveness of sputum cytology using ThinPrep(R) method for evaluation of lung cancer.
- Development and studies of the anti-R7V neutralizing antibody ELISA test: A new serological test for HIV seropositive patients.
- Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis.
- Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
- Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infection.
- Tumor markers in staging and prognosis of colorectal carcinoma.
- Factors Associated With Off-Label Use of Drug-Eluting Stents in Patients With ST-Elevation Myocardial Infarction.
- Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
- The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention insights from a large regional registry of contemporary percutaneous coronary intervention.
- Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.